Zhiqiang Du

机构：Jiangnan University, Shanghai University of Traditional Chinese Medicine, Wuxi Fourth People's Hospital, Jiangxi Mental Health Center · ORCID：0000-0003-0686-1891

发表论文 21 篇 · 总被引 210 次 · h-index 8

代表论文

• Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice (2021 · iScience · 被引 49)
• Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database (2023 · Asian Journal of Psychiatry · 被引 38)
• Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database (2024 · Journal of Affective Disorders · 被引 21)
• Bidirectional causal association between ischemic stroke and five mental disorders (2023 · Acta Psychiatrica Scandinavica · 被引 17)
• Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity (2021 · Archives of Endocrinology and Metabolism · 被引 16)
• Clinical safety of daridorexant in insomnia treatment: Analysis of FDA adverse event reports (2024 · Journal of Affective Disorders · 被引 13)